Nuwellis Inc. (NUWE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nuwellis Inc. (NUWE:NASDAQ), powered by AI.

Current Price
$0.17
P/E Ratio
-0.0
Market Cap
115,392
Sector
Healthcare
What is the Nuwellis Inc. stock price forecast?

Nuwellis Inc. is currently trading at $0.17. View real-time AI analysis on Alpha Lenz.

What is Nuwellis Inc. insider trading activity?

View the latest insider trading data for Nuwellis Inc. on Alpha Lenz.

What is Nuwellis Inc.'s P/E ratio?

Nuwellis Inc.'s P/E ratio is -0.0.

Nuwellis Inc.

NASDAQ · NUWE
$0.17-0.26(-61.12%)Market closedNASDAQ regular session 09:30–16:00 ET
Ask about Nuwellis Inc.'s future dividend policy...
Alpha Chat Insight

Nuwellis Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -382.6%.

Ask for details

Company Overview

Nuwellis Inc. is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of fluid overload. Fluid overload can occur due to heart failure, renal failure, and other critical conditions that lead to excess fluid retention in the body. Nuwellis's primary offering, the Aquadex SmartFlow system, is designed to remove excess fluid safely, predictably, and gently. The technology is particularly beneficial for patients who fail to respond adequately to diuretics. Operating within the medical equipment and supplies sector, Nuwellis Inc. addresses a crucial need in healthcare, providing solutions that improve patient outcomes and reduce hospital stays. The company's products are essential in hospitals and clinics, facilitating the management of fluid overload patients beyond conventional treatment options. By focusing on a niche yet essential area in healthcare, Nuwellis plays a significant role in enhancing patient care standards, offering tools that aid physicians globally. Headquartered in Eden Prairie, Minnesota, Nuwellis Inc. continues to contribute significantly to the advancement of medical technologies in fluid management.

CEOMr. John L. Erb
SectorHealthcare
IndustryMedical Devices
Employees38

Company Statistics

FY 2025

Profile

$115.39KMarket Cap
$8.27MRevenue
0.00Shares Out
38Employees

Margins

61.96%Gross
-129.13%EBITDA
-134.29%Operating
-211.80%Pre-Tax
-211.86%Net

Valuation

-0.01P/E
0.04P/B
0.01EV/Sales
0.06EV/EBITDA
-0.01P/FCF

Growth (CAGR)

-1.08%Rev 3Yr
2.14%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-219.26%ROA
-382.55%ROE
-87.14%ROIC

Financial Health

$1.08MCash & Cash Equivalents
$2.40MNet Debt
132.62%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Nuwellis Inc. (ticker: NUWE) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 38 employees. Market cap is $115,392.

The current price is $0.167 with a P/E ratio of -0.01x and P/B of 0.04x.

ROE is -382.55% and operating margin is -134.29%. Annual revenue is $8M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Nuwellis Inc. (NUWE) Stock Forecast 2026 $0.17 — Price, Financials & Analyst Targets | Alpha Lenz